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AlbuminAbstract Malnutrition is highly prevalent in dialysis patients, and a major contributor to morbid-
ity and mortality. We have investigated the inter-relationship between malnutrition and its impact
on morbidity and mortality in peritoneal dialysis (PD) patients. We enrolled 60 PD patients, and
measured C-reactive protein (CRP) and various nutritional markers, including pre-albumin.
Patients were classiﬁed into two groups according to the albumin level since albumin is a good mar-
ker of nutrition condition: Group I (n= 32) patients with normal albumin (NAP) where the albu-
min level was above or equal to 35 g/L and Group II (n= 28) patients with low albumin level
(LAP) less than 35 g/L. The level (mean ± SD) of blood urea nitrogen was signiﬁcantly high
(p< 0.05) in NAP group (19.9 ± 5.76 mmol/L) compared with LAP group (15.9 ± 6.32 mmol/
L). Data showed that, the mean of creatinine was signiﬁcantly high (p< 0.01) in NAP group
(921 lmol/L) compared with LAP group (584 lmol/L) (Table 2). There was a trend toward associ-
ation of elevated CRP with all-cause mortality in PD patients. It is useful to incorporate albumin
and CRP in the regular assessment of PD patients, whose survival may be improved by better man-
agement of malnutrition.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Malnutrition is highly prevalent among dialysis patients. The
nutritional status of dialysis patients can be determined by bio-
chemical assays, protein catabolic rate (PCR), anthropometry,
and body composition methods. Over the last decade, several
nutritional parameters have emerged as strong predictors of
mortality in dialysis patients. Measures of visceral (serum
albumin and cholesterol) and somatic protein (creatinine)
stores have been well-described predictors of survival in
hemodialysis (HD) and peritoneal dialysis (PD) patients
Table 1 Sociodemgraphic ﬁndings of PD patients.
Sociodemographic
parameters
Distribution Frequency Percentage
Sex Male 15 25.0
Female 45 75.0
60 100.0
Age (years) 18–30 10 16.7
31–45 18 30.0
46–60 12 20.0
Above 60 20 33.3
60 100.0
S1060 A.M. Al-Othman et al.(Avram et al., 1995; Lowrie and Lew, 1990; Avram et al., 1996;
Ducloux et al., 2002; Herzig et al., 2001). Serum albumin has
received increasing attention among newer indices. Due to its
rapid turnover rate, short half-life, high tryptophan content,
and small pool size, albumin is a highly sensitive marker of
nutritional status (Mears, 1996). Chertow et al. (2000) have
shown that albumin provides prognostic value in HD patients.
Kidney disease is emerging as a serious health problem in
this country especially the end stage renal disease. The total
number of patients with end-stage renal disease (ESRD) in
the Middle East is almost 100,000, the mean prevalence being
430 per million population (pmp) (Najaﬁ, 2009). Peritoneal
dialysis is an important treatment modality for end stage renal
disease (ESRD) as hemodialysis. Since peritoneal dialysis has
been gaining wider usage, therefore both continuous ambula-
tory peritoneal dialysis (CAPD) and continuous cycling perito-
neal dialysis (CCPD) have increased accordingly (Gao et al.,
1999). Peritoneal dialysis is now an established therapy for pa-
tients with end stage renal failure. The technique is used by
more than 100,000 renal patients in the developed world. They
concluded that, it is a better procedure at preserving the resid-
ual function of the kidney than hemodialysis (Yung and Mao-
Chan, 2003).
Most of the work linking malnutrition and other factors
has been done in HD patients using CRP and other acute-
phase proteins with serum albumin. There is a paucity of liter-
ature concerning the malnutrition of PD patients, as indicated
by prealbumin and little data available in PD patients. In the
present study, we evaluated the nutritional status, other factors
and their impact on morbidity and mortality in PD patients of
Saudi population.
2. Material and methods
2.1. Patients
Sixty patients who were diagnosed with ESRD and were on
PD whether CAPD or APD for more than 4 months, doing
(PET) study were selected from the peritoneal dialysis ward
and peritoneal dialysis clinic at Security Force Hospital and
Riyadh Al-kharj Hospital, Riyadh, KSA.
All patients were saudis, above 18 years and, free from
chronic degenerative diseases such as cancer, or peritontis. Fe-
male subjects were not pregnant. Patients were classiﬁed into
two groups according to the albumin level since albumin is a
good marker for nutrition condition: Group I (n= 32) pa-
tients with normal albumin (NAP) where the albumin level
was above or equal to 35 g/L and Group II (n= 28) patients
with low albumin level (LAP) less than 35 g/L. The proforma
(Questionnaire) was used for collecting the clinical characteris-
tics of patients. Patients were followed until April 2003. Gen-
eral and demographic information (age, gender, diagnosis, co-
morbidities, and clinical and dialysis history) were collected.
2.2. Laboratory analysis
Non-fasting blood samples were collected at a routine monthly
visit and a multiphasic biochemistry screen including albumin,
creatinine, blood urea nitrogen (BUN), total cholesterol, preal-
bumin, random glucose, phosphorus, potassium, total protein,
sodium, triglyceride, calcium, uric acid and CRP were per-formed. Albumin concentration was determined by the bro-
mocresol green method. Prealbumin and CRP were
measured by immunoturbidimetric method (Spectra East,
Rockleigh, NJ, USA). CRP values less than 15 mg/L were con-
sidered normal. Serial measurements of CRP, prealbumin,
albumin, creatinine, BUN, and nPCR were recorded.
2.3. Statistical analysis
This is a cross-sectional study to evaluate the nutritional status
of 60 PD patients who were on CAPD and APD, for more
than 4 months. Continuous variables were reported as
mean ± SD. For selected comparisons between group means,
parametric (t-test) or non-parametric (Mann–Whitney test)
tests were used. Calculations were performed using SPSS for
Windows 10.0.1 (SPSS Inc., Chicago, IL, USA). P< 0.05
was considered statistically signiﬁcant.
3. Results
3.1. Demographics and patient characteristics
All participants were adults above 18 years, 33.3% above
60 years. Table 1 showed that, 25% were males and 75% were
females. The causes of end stage renal failure were as follows:
diabetic and hypertensive, diabetic nephropathy, hypertensive
nephropathy, bilateral small kidney. The percentages of these
diseases were 36.5%, 3.2%, 17.5%, 15.9%, respectively.
3.2. Laboratory data analysis
The level of albumin was considered low if it is below 35 gm/L.
The results in Table 2 showed that the level (mean ± SD) of
blood urea nitrogen was signiﬁcantly high (p< 0.05) in NAP
group (19.9 ± 5.76 mmol/L) compared with LAP group
(15.9 ± 6.32 mmol/L). Data showed that, the mean of creati-
nine was signiﬁcantly high (p< 0.01) in NAP group
(921 lmol/L) compared with LAP group (584 lmol/L) (Ta-
ble 2). There were no signiﬁcant differences in the levels of
hemoglobin, transferrin, total protein, blood uric acid, choles-
terol. Data showed that the mean of random blood glucose
was signiﬁcantly high (P< 0.05) in LAP group (10.1 versus
6.9 mmol/L) compared with NAP group. The mean of creati-
nine clearance showed no signiﬁcant differences between
LAP group and NAP (Table 2).
Data showed no signiﬁcant differences in mean levels of
biochemical tests such as blood urea nitrogen (17.7 versus
Table 3 Biochemical parameters of the patients according to the type of peritoneal dialysis.
Biochemical tests CAPD patients APD patients P
Mean ± SD Mean ± SD
Blood urea nitrogen (mmol/L) 17.6 ± 6.62 19.0 ± 5.37 0.46
Creatinine (lmol/L) 799 ±93.2 654 ± 293.4 0.11
Total protein (g/L) 63.4 ± 5.2 70.0 ± 6.48 0.11
Albumin (g/L) 35.5 ± 4.86 32.33 ± 5.66 0.06
Uric acid (lmol/L) 346 ± 73.9 461 ± 86.0 0.01*
Hemoglobin (g/L) 119 ± 16.9 116 ± 14.9 0.57
Transferrin (g/L) 1.8 ± 0.33 1.7 ± 0.61 0.63
Cholesterol (mmol/L) 4.6 ± 1.01 4.2 ± 0.95 0.36
Random blood glucose (mmol/L) 8.54 ± 6.1 8.2 ± 4.5 0.83
Triglyceride (mmol/L) 2.22 ± 1.5 1.5 ± 0.67 0.53
Creatinine clearance (L/week)s 51.9 ± 11.4 55.8 ± 12.7 0.31
* (p< 0.05).
Table 2 Biochemical parameters of patients according to the blood albumin levels.
Biochemical tests (units) NAP LAP P
Mean ± SD Mean ± SD
n= 32 n= 28
Blood urea nitrogen (mmol/L) 19.9 ± 5.76 15.9 ± 6.32 .01*
Creatinine (lmol/L) 921 ± 305.3 584 ± 151 0.001**
Total protein (g/L) 65.1 ± 17.6 65.2 ± 8.4 0.97
Albumin (g/L) 38.5 ± 2.6 30.2 ± 3.6 0.001**
Uric acid (lmol/L) 379 ± 69.8 349 ± 112.2 0.31
Hemoglobin (g/L) 116 ± 15.6 121 ± 17.0 0.22
Transferrin (g/L) 2.0 ± 0.25 1.59 ± 0.48 0.01*
Cholesterol (mmol/L) 4.5 ± 0.93 4.5 ± 1.09 0.91
Random blood glucose (mmol/L) 6.9 ± 3.97 10.1 ± 6.87 0.02*
Triglyceride (mmol/L) 2.4 ± 1.5 1.6 ± 1.02 0.43
Creatinine clearance (L/w) 4.5 ± 0.93 4.5 ± 1.09 0.91
* (p< 0.05).
** (p< 0.01).
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terol (4.6 versus 4.2 mmol/liter), triglycerides (2.22 versus
1.5 mmol/liter) and creatinine clearance (51.9 versus 55.8 liter
per week) in patients treated with CAPD compared with pa-
tients treated with APD respectively. The data showed that,
the total proteins were signiﬁcantly higher (p< 0.05) in pa-
tients treated with CAPD compared to patients treated with
APD. Results indicated that sodium level was signiﬁcantly
higher (p< 0.05) in patients treated with APD compared to
patients treated with CAPD. Uric acid was signiﬁcantly
(p< 0.01) low in patients treated with CAPD (346 lmol/L)
compared to patients treated with APD (461 lmol/L) as illus-
trated in (Table 3).4. Discussion
The present study, found that there are many indicators such
as age, dietary intake, inadequate dialysis, serum albumin le-
vel, and the presence of associated diseases that affect the
nutritional status of PD patients and might be the cause to
malnutrition and contributing to morbidity and mortality.The results of this study conﬁrm the relationship between
indicators of malnutrition and measures of inﬂammation in
PD patients. The present study was carried out to evaluate
the nutrition status of 60 chronic renal failures on CAPD
and APD. The results showed that 46.6% of the patients were
malnourished. It is well established that serum levels of nutri-
tional markers such as albumin, creatinine, and prealbumin
are decreased in malnourished dialysis patients, and that lower
levels of these nutritional markers are associated with in-
creased mortality in these patients (Avram et al., 1995; Avram
et al., 1994; Avram et al., 2001; Combe et al., 2001). In the
present study, we investigated the relationship of albumin to
CRP levels and other nutritional markers in PD patients
grouped by albumin level. 33.3% of patients were aged above
60 year with low serum albumin which was associated with
malnutrition and increased rate of morbidity and mortality.
There are two types of malnutrition in dialysis patients, one
associated with or due to the uremic syndrome, and the other
with comorbid conditions and inﬂammation, as suggested by
Stenvinkel et al. (2000). Serum creatinine is a marker of so-
matic protein stores, but unlike prealbumin, serum creatinine
is not a negative acute-phase protein. This relationship be-
tween CRP and creatinine implies a link between malnutrition
S1062 A.M. Al-Othman et al.and inﬂammatory state in PD patients. In addition, in the pres-
ent study 41.7% of the patients were having nausea and 25.4%
were having poor appetite which are important factors for
inadequate nutrition in CAPD. These results agreed with the
data reported by Passadakis et al. (1999).
Serum albumin, also a negative acute-phase protein, is the
most widely used nutritional marker in dialysis patients. Our
data showed that 44.4% of patients have serum albumin level
less than 35 g/L (Table 2). There are conﬂicting reports in the
literature regarding the association between CRP and albumin
in dialysis patients. Qureshi et al. (1998) have found an associ-
ation of CRP with albumin. In addition, lower serum albumin
has been reported in continuous ambulatory peritoneal dialysis
(CAPD) patients with persistently elevated CRP level (Kim
et al., 2002).
5. Conclusions
The assessment of the nutritional status of 60 patients under
going peritoneal dialysis was performed. Morbidity is common
among these patients. The most important factor for Protein-
energy malnutrition (PEM) among these patients, old age,
inadequate nutrient intake, high membranes transport cavity,
change in smell and taste and low serum albumin, poor appe-
tite, constipation.
In a nutshell, our study presents evidence for an inter-rela-
tionship between malnutrition and inﬂammation markers in
PD patients. Although a negative acute-phase protein, serum
prealbumin predicts nutritional status independent of inﬂam-
matory state. Regular measurement of serum prealbumin
and CRP may increase the comprehensive assessment of over-
all status of health in PD patients. We concluded that the fre-
quency of malnutrition is high in our population. Poor protein
intake has the strongest correlation with malnutrition in PD
patients. The inﬂuence of poor protein intake on nutritional
status of PD patients is greater than morbidities, inﬂamma-
tion, and decreased energy intake. Providing, enough protein
may be an effective way in preventing malnutrition in these pa-
tients. Identiﬁcation and management of malnutrition should
improve survival in PD patients.Acknowledgment
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